FdaApplication
ANDA 210451
Identifiers
- fda_app_no: ANDA210451
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMS USA |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CANAGLIFLOZIN | CANAGLIFLOZIN | 300mg | TABLET;ORAL |
1 product